Stock listing

Neurocrine Biosciences, Inc.

Selected listing: NB3 · DUS · EUR · DE

Neurocrine Biosciences, Inc. (Dusseldorf:NB3), Health Technology. Latest release Sep 30, 2026: Neurocrine Biosciences to Present Research Advancing…

NB3:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:NB3
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Dusseldorf
Currency: EUR

About Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (ticker: NBIX) is a public company based in America, specializing in biopharmaceuticals. The company is committed to advancing innovative therapies to improve patient outcomes.

Latest news from Neurocrine Biosciences, Inc.

Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference

September 30, 2026

Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference

September 29, 2026

Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer

September 28, 2026

Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living with Tardive Dyskinesia

August 12, 2026

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist

August 7, 2026

All Neurocrine Biosciences, Inc. news →

Events

Replays

Neurocrine Biosciences, Inc. (NBIX) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 04:30 PM ET
Watch
Neurocrine Biosciences, Inc. (NBIX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 04:30 PM ET
Watch
Neurocrine Biosciences, Inc. (NBIX) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 04:30 PM ET
Watch

Research Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. company profile

View the public company page for Neurocrine Biosciences, Inc. on 6ix.

Neurocrine Biosciences, Inc. news

Read company news and market updates connected to Neurocrine Biosciences, Inc..

Neurocrine Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Neurocrine Biosciences, Inc..